Our Team

Efficient. Experienced. Exclusively oncology-focused. The HMP Market Access Insights team includes a deep roster of high-quality talent with sophisticated analytical capabilities who leverage more than 50 years of experience engaging with healthcare providers, payers, and cancer drug developers.
Lee Blansett
Lee Blansett
Executive Vice President

Lee Blansett has been an active participant in the US healthcare system for more than 20 years. His research into health system organizations and oncology market access topics includes extensive on-the-ground studies in the US and EU. Lee’s previous work includes internal consulting roles with APM, Kaiser Permanente, Stanford Children’s Hospital, and a community oncology group. His work on manufacturers’ behalf includes serving as a Senior Vice President at DaVinci Oncology/Kantar and as a Senior Principal with the IMS Consulting Group. His academic training includes an MBA from the Wharton School and a BSC in finance from Santa Clara University, where he was a National Merit Scholar. 

Cindy Chen.
Cindy Chen
Head of Data Analytics

Cindy Chen oversees HMP Market Access Insights’ quantitative research initiatives in oncology and assists with our clinical evidence initiative, exploring payer data requirements for coverage of gene therapies and other products addressing rare diseases. Cindy has worked with multiple global life sciences companies while at Strategic Decisions Group, IMS Consulting Group, and as an independent consultant. She has helped pharmaceutical companies evaluate development strategies for pipeline candidates, supported long-term strategic planning, and optimized portfolios of development and in-market franchises. Cindy holds an MBA from the Wharton School of Business, a bachelor’s in business administration from the Haas School at UC Berkeley and is a Certified Public Accountant.

Chris Van Denburg.
Chris Van Denburg
Director

Chris Van Denburg’s career focuses entirely on studying the healthcare system and its adoption of novel treatments. His work over the last two decades has covered the spectrum of market access, including roles in market research, data analytics, marketing, pricing and contracting, operations, training, special pharmacy partnership programs, and patient support services. His corporate experience includes both large and small biopharmaceutical companies, in addition to serving as an external consultant to several companies.

Chris holds a bachelor's degree from Ithaca College, and has direct oncology laboratory and clinical research experience at the Strang-Cornell Cancer Research Laboratory and Strang Cancer Prevention Center.

Emma Bijesse headshot.
Emma Bijesse
Director

Emma Bijesse supports HMP Market Access Insights quantitative and qualitative research with over 10 years of experience supporting academic health systems and integrated delivery networks. Emma’s previous experience includes leading strategy engagements as an Associate Principal at Chartis, including oncology service line growth planning, partnership support, and financial forecasting and analyses. Prior to Chartis, Emma supported genetic testing and population health management programs at Kaiser Permanente. Emma holds an MBA from the Kellogg School of Management at Northwestern University, where she majored in finance and operations. She also received a bachelor's degree in economics from the University of California, Berkeley. 

Taylor Crutison.
Taylor Crutison
Senior Consultant

Taylor Crutison is a Senior Consultant at HMP Market Access Insights who focuses on primary and secondary research and data analysis. Her interest in oncology began at Dana-Farber Cancer Institute, where she engaged with patients to assess readiness for digital health tools and identified improvement areas in Dana-Farber’s patient reported outcomes data collection system. Additionally, her previous provider experiences include internships at Kaiser Permanente and a small community health nonprofit.

Taylor holds an MPH from Columbia University’s Mailman School of Public Health, where her studies focused on health policy and management, and a bachelor’s degree in human biology from Stanford University.

Efficient. Experienced. Exclusively oncology-focused. The HMP Market Access Insights team includes a deep roster of high-quality talent with sophisticated analytical capabilities who leverage more than 50 years of experience engaging with healthcare providers, payers, and cancer drug developers.

Our Advisors

We engage in ongoing dialogue with our own trusted advisors representing providers and payers to ensure that we do not miss any key topics and that we grasp a deep understanding of their implications. Their current and seasoned perspectives show up in our analytics and help us deliver actionable insights pertinent to our subscribers’ business needs.